We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reaching Training Based on Robotic Hybrid Assistance for Stroke Patients ( RETRAINER-S2 ) (RETRAINER-S2)

This study is currently recruiting participants.
Verified November 2017 by Dr. Franco Molteni, Villa Beretta Rehabilitation Center
Sponsor:
ClinicalTrials.gov Identifier:
NCT03199833
First Posted: June 27, 2017
Last Update Posted: November 9, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Ecole Polytechnique Fédérale de Lausanne
Ab.Acus, Milan, Italy
Control Systems Group, Technische Universität Berlin, Germany
Ottobock Health Products GmbH, Wien, Austria
Hasomed GmbH, Magdeburg, Germany
Asklepios Neurologische Klinik Falkenstein, Königstein, Germany
Technische Universität Wien, Austria
Dept. of Electronics, Informatics, Bioengineering, Politecnico di Milano, Italy
Information provided by (Responsible Party):
Dr. Franco Molteni, Villa Beretta Rehabilitation Center
  Purpose

Stroke is the third most common cause of death and the main cause of acquired adult disability in high-income countries. The most common deficit after stroke is motor impairment of the contralateral arm, with more than 80% of stroke survivors experiencing this condition in the acute phase, and only half regaining some useful upper limb function after six months.

Within the European project RETRAINER (grant agreement No 644721), the consortium developed a platform for the rehabilitation of the upper limb after stroke, which combines a passive forearm-hand orthosis for hand-wrist motion stabilization, selective fingers constraining and grasp movement facilitation, Functional Electrical Stimulation (FES) of the extrinsic hand flexor muscles and of the extrinsic hand extensor muscles, interactive objects, and voluntary effort. The system also provides a graphical user interface which helps the therapist set the training session and save the training data and parameters, and provides the subject a visual feedback about his/her active involvement in the exercise. The training consists of the execution of a series of exercises involving the affected arm during daily life activities. Typical exercises include controlled wrist flexion and extension, controlled fingers flexion and extension, anterior reaching and grasping on a plane or in the space, moving an object on a plane or in the space.

The aim of this clinical study it to evaluate the efficacy of this novel training platform on patients between two weeks and nine months after their first stroke, who preserved at least a visible muscle contraction for the arm and shoulder muscles. Participants are randomized in an experimental and a control group. The control group is trained with an advanced rehabilitative program, including physical training, occupational therapy, FES, and virtual reality, while the experimental group is trained with the RETRAINER system for about 30 minutes, in addition to the same program of the control group. The daily training time is the same for the two groups. The intervention consists of three sessions a week for nine weeks. Patients are assessed at baseline, soon after the end of the intervention, and in a 4-week follow-up visits. It is planned to recruit 68 subjects for this study. Since the RETRAINER platform was built on the up-to-date theory of motor re-learning, which supports task-oriented repetitive training, a close temporal association between motor intention and stimulated motor response, and an intensive and frequent training paradigm, the study's hypothesis is that the experimental group shows a greater treatment effect than the control group.


Condition Intervention
Stroke Device: RETRAINER-S2 Other: Conventional therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Reaching Training Based on Robotic Hybrid Assistance for Stroke Patients

Resource links provided by NLM:


Further study details as provided by Dr. Franco Molteni, Villa Beretta Rehabilitation Center:

Primary Outcome Measures:
  • Action Research Arm Test [ Time Frame: 9 weeks ]

    9-item outcome measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from:

    • 3: Performs test normally
    • 2: Completes test, but takes abnormally long or has great difficulty
    • 1: Performs test partially
    • 0: Can perform no part of test


Secondary Outcome Measures:
  • Action Research Arm Test [ Time Frame: 13 weeks ]

    9-item outcome measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from:

    • 3: Performs test normally
    • 2: Completes test, but takes abnormally long or has great difficulty
    • 1: Performs test partially
    • 0: Can perform no part of test

  • Medical Research Council [ Time Frame: baseline; 9 weeks; 13 weeks ]
    A standardized assessment to measure muscle strength; Score range 0-5 (minimum 0, maximum 5)

  • Motricity index [ Time Frame: baseline; 9 weeks; 13 weeks ]
    Outcome measure to evaluate motor impairment after stroke; 2 sub-scales (arm and leg); each subscale ranges from 0 (maximal impairment) to 100 (no impairment)

  • Motor Activity Log [ Time Frame: baseline; 9 weeks; 13 weeks ]

    Semi-structured interview to assess arm function. Individuals are asked to rate Quality of Movement and Amount of Movement during 30 daily functional tasks. Target tasks include object manipulation (e.g. pen, fork, comb, and cup) as well as the use of the arm during gross motor activities (e.g. transferring to a car, steadying oneself during standing, pulling a chair into a table while sitting).

    Items scored on a 6-point ordinal scale (0 not used, 6 as good as before).


  • Box & Blocks Test [ Time Frame: baseline; 9 weeks; 13 weeks ]

    It assesses unilateral gross manual dexterity. Individuals are seated at a table, facing a rectangular box that is divided into two square compartments of equal dimension by means of a partition.

    One hundred and fifty, 2.5 cm, colored, wooden cubes or blocks are placed in one compartment or the other. The individual is instructed to move as many blocks as possible, one at a time, from one compartment to the other for a period of 60 seconds.

    To administer the test, the examiner is seated opposite the individual in order to observe test performance.

    The test is scored by counting the number of blocks carried over the partition from one compartment to the other during the one-minute trial period.


  • Stroke Specific Quality Of Life scale [ Time Frame: baseline; 9 weeks; 13 weeks ]

    It assesses the health-related quality of life specific to stroke survivors.

    It consists of 49 items, each assessed on 5-point Guttman-type scales. Score range: 49-245 with higher score indicating better functioning. It covers 12 domains which are:

    • Mobility
    • Energy
    • Upper Extremity Function
    • Work and Productivity
    • Mood
    • Self-care
    • Social Roles
    • Family Roles
    • Vision
    • Language
    • Thinking
    • Personality

  • Modified Ashworth Scale [ Time Frame: baseline; 9 weeks; 13 weeks ]

    It measures spasticity. It consists of a test resistance to passive movement about a joint with varying degrees of velocity. Scores range from 0-5; a score of 0 indicates no resistance, 5 indicates rigidity.

    target muscles: Wrist flexor and extensor, fingers and thumb flexor and extensor


  • Instrumental assessment [ Time Frame: baseline; 9 weeks; 13 weeks ]
    Dynamic electromyography (EMG) signals of the Wrist flexor and extensor, fingers and thumb flexor and extensor as well as kinematic data are measured during free-movement of the wrist and the hand

  • System Usability Scale [ Time Frame: 9 weeks ]
    A 10-item questionnaire to measure system usability. Each item has five response options, from "Strongly agree" to "Strongly disagree".

  • Technology Acceptance Model [ Time Frame: 9 weeks ]

    A standardized questionnaire that measures technology acceptance. The questionnaire consists of 2 parts, 10 items to measure usefulness and 10 items to measure ease of use.

    Participants are asked to provide their level of agreement on a 7-point scale (1=strongly disagree and 7 = strongly agree).



Estimated Enrollment: 68
Actual Study Start Date: November 10, 2016
Estimated Study Completion Date: May 2018
Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Arms
RETRAINER-S2 & Conventional Therapy 27 sessions, 3 sessions per week for a total of 9 weeks. Each session consists of 30-minute training with the RETRAINER-S2 system plus 60 minutes of conventional therapy. The training session is customized on the patients' need and can be adapted to their improvement during the intervention.
Device: RETRAINER-S2

It consists of the execution of different exercises with the affected forearm-hand supported by the RETRAINER-S2 device. The subject is actively involved in the exercises and the system provides two types of support: wrist-fingers motion constraining and FES. The following exercises can be performed: controlled wrist flexion and wrist extension; controlled fingers flexion and extension; repeated grasping of an object; anterior reaching and grasping of an object; moving of objects on a plane or in space.

A subset of exercises is defined based on the patient's capability and the training time is equally shared between the selected exercises. The different training sessions can include different exercises and a different number of repetition for each exercise.

Other: Conventional therapy

It consists of a combination of different treatment modalities among the following, based on the patient's specific needs:

  • Upper limb passive motion
  • Arm Cycle ergometer with or without FES
  • Neuro Muscular Electrical Stimulation
  • Upper limb exercises using augmented or virtual reality environment
  • Occupational therapy exercises
  • Constraint induced movement therapy
  • Upper limb active movement (reaching, grasping, elevation, spatial orientation)
  • Repetitive task training
  • Mirror therapy
  • Writing training
  • Chemodenervation Therapy
Active Comparator: Conventional Therapy
27 sessions, 3 sessions per week for a total of 9 weeks. Each session lasts about 90 minutes and consists of different training modalities typically used in the rehabilitation of the arm after stroke. The training session is customized on the patients' need and can be adapted to their improvement during the intervention.
Other: Conventional therapy

It consists of a combination of different treatment modalities among the following, based on the patient's specific needs:

  • Upper limb passive motion
  • Arm Cycle ergometer with or without FES
  • Neuro Muscular Electrical Stimulation
  • Upper limb exercises using augmented or virtual reality environment
  • Occupational therapy exercises
  • Constraint induced movement therapy
  • Upper limb active movement (reaching, grasping, elevation, spatial orientation)
  • Repetitive task training
  • Mirror therapy
  • Writing training
  • Chemodenervation Therapy

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults male and/or female, 18-85 years old
  • Patients who have suffered a first stroke with major unilateral functional impairment
  • Acute event between two weeks and nine months before study enrollment
  • Motricity Index of the affected side must be under 80% of best expected performance.
  • No major contralateral impairment must be present (Motricity Index of the non-affected side more than 80% of normality)
  • Residual muscular activity for forearm muscles (MRC > o = 1)
  • Mini-Mental State Examination > 20

Exclusion Criteria:

  • Limitation for using the device due to impairment of Passive Range of Motion and/or
  • Pain due to Spasticity evaluated using Modified Ashworth Scale
  • Previous history of major neurological or psychiatric disorders
  • allergy to electrodes
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03199833


Contacts
Contact: Giovanna Palumbo +390318544215 gpalumbo@valduce.it
Contact: Mauro Rossini +390318544217 mrossini@valduce.it

Locations
Germany
Asklepios Neurologische Klinik Falkenstein Recruiting
Konigstein im Taunus, Germany, 61462
Contact: Karsten Krakow, MD       k.krakow@asklepios.com   
Principal Investigator: Karsten Krakow, MD         
Italy
Villa Beretta Rehabilitation Center Recruiting
Costa Masnaga, Lecco, Italy, 23845
Contact: Giulio Gasperini, MD    +390318544211    ggasperini@valduce.it   
Principal Investigator: Franco Molteni, MD         
Sub-Investigator: Giulio Gasperini, MD         
Sponsors and Collaborators
Dr. Franco Molteni
Ecole Polytechnique Fédérale de Lausanne
Ab.Acus, Milan, Italy
Control Systems Group, Technische Universität Berlin, Germany
Ottobock Health Products GmbH, Wien, Austria
Hasomed GmbH, Magdeburg, Germany
Asklepios Neurologische Klinik Falkenstein, Königstein, Germany
Technische Universität Wien, Austria
Dept. of Electronics, Informatics, Bioengineering, Politecnico di Milano, Italy
Investigators
Principal Investigator: Franco Molteni, MD Villa Beretta Rehabilitation Center
  More Information

Additional Information:
Responsible Party: Dr. Franco Molteni, Clinical Director, Villa Beretta Rehabilitation Center
ClinicalTrials.gov Identifier: NCT03199833     History of Changes
Other Study ID Numbers: RETRAINER-S2
First Submitted: June 23, 2017
First Posted: June 27, 2017
Last Update Posted: November 9, 2017
Last Verified: November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Dr. Franco Molteni, Villa Beretta Rehabilitation Center:
rehabilitation
orthosis
functional electrical stimulation
electrode array
upper limb
sub-acute
motor relearning

Additional relevant MeSH terms:
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases